GE HealthCare Technologies Inc.
GEHCNasdaq · SIC 3844
$63.07
↓ -4.0%Jul 17 close · end-of-day
Price
1Y↓ -16.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$28.8B
Enterprise Value
$36.7B
P/E
15.1
P/S
1.4
P/B
2.7
EV/EBITDA
12.4
PEG
6.0
FCF Yield
—
Dividend Yield
0.2%
Revenue (TTM)
$21.0B
Net Income (TTM)
$1.9B
Free Cash Flow (TTM)
—
Gross Margin
39.1%
Operating Margin
12.6%
Net Margin
9.1%
ROE
17.9%
ROIC
10.9%
Debt / Equity
0.9
Net Cash
-$7.9B
Return 1Y
-17.1%
Company profile
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator. It serves customers in more than 160 countries with a global team of over 10,000 sales representatives, 8,500 field service engineers and 43 manufacturing sites across 17 countries.
- CEO
- Peter J. Arduini
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 50,000
- Headquarters
- Illinois
Management & directors
- Bankes JeannetteCEO, Patient Care Solutions
- Rackliffe PhilipCEO, AIS
- Saccaro JamesChief Financial Officer
- Arduini Peter JPresident and CEO
- Jimenez Frank RGC & Corporate Secretary
- Holton Adam YChief People Officer
- Kass-Hout TahaChief Technology Officer
- Newcomb George A.Chief Accounting Officer
- O'Neill Kevin MichaelCEO, PDx
- Rott RolandCEO, Imaging
- Stacherski Kenneth R.Chief Enterprise Oper. Officer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-07-29
GEHC Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$5.1B↑ +7.4%
Diluted EPS$0.85↓ -30.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.6B | $18.3B | $19.6B | $19.7B | $20.6B |
| Gross profit | $7.2B | $7.2B | $7.9B | $8.2B | $8.2B |
| Operating income | $2.8B | $2.5B | $2.4B | $2.6B | $2.8B |
| Net income | $2.2B | $1.9B | $1.6B | $2.0B | $2.1B |
| Diluted EPS | $4.95 | $4.22 | $3.03 | $4.34 | $4.55 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Gross margin | 40.8% | 39.1% | 40.5% | 41.7% | 40.0% |
| Operating margin | 15.9% | 13.8% | 12.5% | 13.3% | 13.4% |
| Net margin | 12.8% | 10.4% | 8.0% | 10.1% | 10.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $4.9B | $5.3B | $4.8B | $5.0B | $5.1B | $5.7B | $5.1B |
| Gross profit | $2.0B | $2.0B | $2.3B | $2.0B | $2.0B | $2.0B | $2.3B | $2.0B |
| Operating income | $608.0M | $676.0M | $801.0M | $629.0M | $654.0M | $653.0M | $827.0M | $515.0M |
| Net income | $428.0M | $470.0M | $721.0M | $564.0M | $486.0M | $446.0M | $588.0M | $389.0M |
| Diluted EPS | $0.93 | $1.02 | $1.58 | $1.23 | $1.06 | $0.98 | $1.28 | $0.85 |
| Operating cash flow | -$119.0M | — | — | $250.0M | $94.0M | — | — | $290.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 41.4% | 41.7% | 42.8% | 42.1% | 39.6% | 38.7% | 39.7% | 38.5% |
| Operating margin | 12.6% | 13.9% | 15.1% | 13.2% | 13.1% | 12.7% | 14.5% | 10.0% |
| Net margin | 8.8% | 9.7% | 13.6% | 11.8% | 9.7% | 8.7% | 10.3% | 7.6% |
Company news
Jul 17, 2026
Jul 16, 2026
- 4d agoGE HealthCare (GEHC) Lands $500 Million Catholic Health Deal For Imaging And AIfinance.yahoo.com
- 4d agoCatholic Health and GE HealthCare partner to expand patient access across Long Islandfinance.yahoo.com
- 4d agoGE HealthCare Technologies (GEHC) Following Mayo Clinic Trial Tie Up Faces A Fresh Valuation Testfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-22 | Lobo Kevin | Buy | 10,000 | $64.18 | $641,800.00 | filing |
| 2026-05-15 | Bankes Jeannette· CEO, Patient Care Solutions | Tax withholding | 5,535 | $62.67 | $346,878.45 | filing |
| 2026-05-15 | Rackliffe Philip· CEO, AIS | Award | 16,458 | $0.00 | $0.00 | filing |
| 2026-05-12 | Hochman Rodney F | Buy | 1,618 | $62.03 | $100,364.54 | filing |
| 2026-05-08 | Yang Watkin Phoebe L. | Buy | 1,000 | $63.01 | $63,006.30 | filing |
| 2026-05-07 | Hochman Rodney F | Award | 2,689 | $0.00 | $0.00 | filing |
| 2026-05-07 | LESJAK CATHERINE A | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | Lobo Kevin | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | Madden Anne T | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | Madden Anne T | Award | 2,282 | $0.00 | $0.00 | filing |
| 2026-05-07 | Stromberg William J | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | Yang Watkin Phoebe L. | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | CULP H LAWRENCE JR | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-07 | CULP H LAWRENCE JR | Award | 4,157 | $0.00 | $0.00 | filing |
| 2026-05-07 | Hochman Rodney F | Award | 3,586 | $0.00 | $0.00 | filing |
| 2026-05-06 | CULP H LAWRENCE JR | Buy | 80,805 | $61.88 | $5.0M | filing |
| 2026-05-06 | Stromberg William J | Buy | 1,000 | $61.69 | $61,689.20 | filing |
| 2026-05-01 | SACCARO JAMES· Chief Financial Officer | Buy | 3,310 | $60.60 | $200,585.01 | filing |
| 2026-04-30 | Arduini Peter J· President and CEO | Buy | 4,169 | $59.93 | $249,827.33 | filing |
| 2026-04-30 | Jimenez Frank R· GC & Corporate Secretary | Buy | 1,750 | $60.45 | $105,787.50 | filing |
| 2026-03-13 | Lobo Kevin | Award | 777 | $0.00 | $0.00 | filing |
| 2026-03-02 | Newcomb George A.· Chief Accounting Officer | Award | 1,309 | $0.00 | $0.00 | filing |
| 2026-03-02 | O'Neill Kevin Michael· CEO, PDx | Award | 6,549 | $0.00 | $0.00 | filing |
| 2026-03-02 | Rackliffe Philip· CEO, AVS | Award | 9,356 | $0.00 | $0.00 | filing |
| 2026-03-02 | Rott Roland· CEO, Imaging | Award | 8,576 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.